ID Medical Group Limited - Limited company accounts 16.3
ID Medical Group Limited - Limited company accounts 16.3
REGISTERED NUMBER: |
ID MEDICAL GROUP LIMITED |
STRATEGIC REPORT, REPORT OF THE DIRECTORS AND |
FINANCIAL STATEMENTS |
FOR THE YEAR ENDED 31 DECEMBER 2016 |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
CONTENTS OF THE FINANCIAL STATEMENTS |
for the year ended 31 December 2016 |
Page |
Company Information | 1 |
Strategic Report | 2 |
Report of the Directors | 4 |
Report of the Independent Auditors | 6 |
Statement of Comprehensive Income | 8 |
Balance Sheet | 9 |
Statement of Changes in Equity | 10 |
Cash Flow Statement | 11 |
Notes to the Cash Flow Statement | 12 |
Notes to the Financial Statements | 13 |
ID MEDICAL GROUP LIMITED |
COMPANY INFORMATION |
for the year ended 31 December 2016 |
DIRECTORS: |
SECRETARY: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
AUDITORS: |
Chartered Accountants |
Statutory Auditor |
Albury Mill |
Mill Lane |
Chilworth |
Guildford |
Surrey |
GU4 8RU |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
STRATEGIC REPORT |
for the year ended 31 December 2016 |
The directors present their strategic report for the year ended 31 December 2016. |
REVIEW OF BUSINESS |
During the year under review, the company continued, developed and expanded its principal activities, which |
consist of the provision of recruitment services to the healthcare industry, namely the provision of Doctors, |
Nurses and Allied Health Professionals (AHP) to hospitals within the UK. |
The results for the year and financial position of the company as at the year end are as shown in the annexed |
financial statements. |
Key performance indicators |
The directors consider that gross profit and operating profit are the key performance measures in monitoring |
and managing the business. |
The turnover for the year ended 31 December 2016 was £126.7m (2015: £165.1m). Gross profit was £23.9m |
(2015: £26.3m) and operating profit was £1.8m (2015: £4.0m). The directors are satisfied with the results of the |
company for the year in the context of the current economic conditions and given the further investment which |
has been made for the benefit of future years. |
PRINCIPAL RISKS AND UNCERTAINTIES |
The directors regularly review the risks pertinent to the company. The principal risks can be broadly grouped |
into those related to the economic environment, those related to liquidity and those related to the supply of |
locums. |
Economic environment risks |
The company operates in a sector which is largely dependent upon government funding. In order to reduce the |
national deficit the government has continued to focus on costs. The company is proud to work in partnership |
with its clients. These partnerships include the provision of services under government frameworks. The |
company's appointment to national frameworks assures partnering clients of the company's capability to drive |
cost-efficiencies whilst delivering totally sustainable workforce planning. This is one such example of the |
company's ability to deliver added value to its client base. |
Liquidity risks |
This is managed proactively by ensuring that short and medium term cash flow forecasts are supported by |
appropriate debt facilities. The company uses invoice discounting to finance the ongoing working capital. |
Supply of temporary workers |
Demand for both doctors, nurses and AHP's continues and the company has developed its recruitment program |
accordingly. |
Financial Risks |
The directors regularly review future forecasts with specific focus on funding requirements to ensure adequate |
financing is available to support future plans. |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
STRATEGIC REPORT |
for the year ended 31 December 2016 |
FUTURE DEVELOPMENTS |
The company will continue to invest in its divisions (doctors, nurses, AHP) with a view to building upon its strong |
foundations, adding client value and partnering both nationally and internationally. The Company has opened an |
office in India to make use of cost-effective resource available with the dual aim of driving UK growth and |
managing the company cost base in the medium term. |
ON BEHALF OF THE BOARD: |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
REPORT OF THE DIRECTORS |
for the year ended 31 December 2016 |
The directors present their report with the financial statements of the company for the year ended 31 December 2016. |
DIVIDENDS |
The total distribution of dividends for the year ended 31 December 2016 was £1,400,000. |
EVENTS SINCE THE END OF THE YEAR |
Information relating to events since the end of the year is given in the notes to the financial statements. |
DIRECTORS |
The directors shown below have held office during the whole of the period from 1 January 2016 to the date of |
this report. |
Other changes in directors holding office are as follows: |
EMPLOYEE INVOLVEMENT |
The company regularly holds meetings at various levels (e.g. senior management meetings, departmental |
meetings etc.) to encourage employee involvement and contribution. Employees are also kept well-informed |
about the progress and position of the company by means of both these meetings and by other |
communications, as appropriate. |
EMPLOYMENT OF DISABLED PERSONS |
The company's policy is to give full and fair consideration to applicants for employment made by disabled |
persons, having regard to their particular aptitudes and abilities. Disabled employees receive appropriate |
training to promote their career development within the company. Employees who become disabled are |
retained in their existing posts where possible or retained for suitable alternative posts. |
DISCLOSURE IN THE STRATEGIC REPORT |
As permitted by Section 414C(11) of the Companies Act 2006 certain matters which are required to be disclosed |
in the report of the directors' have been omitted as they are included in the strategic report on pages 2 to 3. |
These matters relate to the principal activity and future developments of the company. |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
REPORT OF THE DIRECTORS |
for the year ended 31 December 2016 |
STATEMENT OF DIRECTORS' RESPONSIBILITIES |
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial |
statements in accordance with applicable law and regulations. |
Company law requires the directors to prepare financial statements for each financial year. Under that law the |
directors have elected to prepare the financial statements in accordance with United Kingdom Generally |
Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law |
the directors must not approve the financial statements unless they are satisfied that they give a true and fair |
view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing |
these financial statements, the directors are required to: |
- | select suitable accounting policies and then apply them consistently; |
- | make judgements and accounting estimates that are reasonable and prudent; |
- | state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements; |
- | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. |
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain |
the company's transactions and disclose with reasonable accuracy at any time the financial position of the |
company and enable them to ensure that the financial statements comply with the Companies Act 2006. They |
are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the |
prevention and detection of fraud and other irregularities. |
STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS |
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the |
Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps |
that he ought to have taken as a director in order to make himself aware of any relevant audit information and |
to establish that the company's auditors are aware of that information. |
AUDITORS |
The auditor, Bessler Hendrie, Chartered Accountants, has indicated a willingness to continue in office. |
ON BEHALF OF THE BOARD: |
REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF |
ID MEDICAL GROUP LIMITED |
We have audited the financial statements of ID Medical Group Limited for the year ended 31 December 2016 on |
pages eight to twenty four. The financial reporting framework that has been applied in their preparation is |
applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting |
Practice), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and |
Republic of Ireland'. |
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the |
Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members |
those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the |
fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company |
and the company's members as a body, for our audit work, for this report, or for the opinions we have formed. |
Respective responsibilities of directors and auditors |
Scope of the audit of the financial statements |
A description of the scope of an audit of financial statements is provided on the FRC's website at |
www.frc.org.uk/auditscopeukprivate. |
Opinion on financial statements |
In our opinion the financial statements: |
- | give a true and fair view of the state of the company's affairs as at 31 December 2016 and of its profit for the year then ended; |
- | have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and |
- | have been prepared in accordance with the requirements of the Companies Act 2006. |
Opinion on other matter prescribed by the Companies Act 2006 |
In our opinion, based on the work undertaken in the course of our audit, the information given in the Strategic |
Report and the Report of the Directors for the financial year for which the financial statements are prepared is |
consistent with the financial statements, and has been prepared in accordance with applicable legal |
requirements. In the light of the knowledge and understanding of the company and its environment, we have |
not identified any material misstatements in the Strategic Report or the Report of the Directors. |
REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF |
ID MEDICAL GROUP LIMITED |
Matters on which we are required to report by exception |
We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to |
report to you if, in our opinion: |
- | adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or |
- | the financial statements are not in agreement with the accounting records and returns; or |
- | certain disclosures of directors' remuneration specified by law are not made; or |
- | we have not received all the information and explanations we require for our audit. |
for and on behalf of |
Chartered Accountants |
Statutory Auditor |
Albury Mill |
Mill Lane |
Chilworth |
Guildford |
Surrey |
GU4 8RU |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
STATEMENT OF COMPREHENSIVE INCOME |
for the year ended 31 December 2016 |
2016 | 2015 |
Notes | £ | £ |
TURNOVER | 3 |
Cost of sales | ( |
) | ( |
) |
GROSS PROFIT |
Administrative expenses | ( |
) | ( |
) |
1,719,346 | 3,915,202 |
Other operating income |
OPERATING PROFIT | 6 |
Interest receivable and similar income |
1,783,212 | 3,979,471 |
Interest payable and similar expenses | 8 | ( |
) | ( |
) |
PROFIT BEFORE TAXATION |
Tax on profit | 9 | ( |
) | ( |
) |
PROFIT FOR THE FINANCIAL YEAR |
OTHER COMPREHENSIVE INCOME | - | - |
TOTAL COMPREHENSIVE INCOME FOR THE YEAR |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
BALANCE SHEET |
31 December 2016 |
2016 | 2015 |
Notes | £ | £ |
FIXED ASSETS |
Intangible assets | 11 |
Tangible assets | 12 |
Investments | 13 |
CURRENT ASSETS |
Stocks | 14 |
Debtors | 15 |
Cash at bank and in hand |
CREDITORS |
Amounts falling due within one year | 16 | ( |
) | ( |
) |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CREDITORS |
Amounts falling due after more than one year |
17 |
( |
) |
( |
) |
PROVISIONS FOR LIABILITIES | 20 | ( |
) | ( |
) |
NET ASSETS |
CAPITAL AND RESERVES |
Called up share capital | 21 |
Retained earnings | 22 |
SHAREHOLDERS' FUNDS |
The financial statements were approved by the Board of Directors on behalf by: |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
STATEMENT OF CHANGES IN EQUITY |
for the year ended 31 December 2016 |
Called up |
share | Retained | Total |
capital | earnings | equity |
£ | £ | £ |
Balance at 1 January 2015 |
Changes in equity |
Dividends | - | ( |
) | ( |
) |
Total comprehensive income | - |
Balance at 31 December 2015 |
Changes in equity |
Dividends | - | ( |
) | ( |
) |
Total comprehensive income | - |
Balance at 31 December 2016 |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
CASH FLOW STATEMENT |
for the year ended 31 December 2016 |
2016 | 2015 |
Notes | £ | £ |
Cash flows from operating activities |
Cash generated from operations | 1 | ( |
) |
Finance costs paid | (293,500 | ) | (356,945 | ) |
Tax paid | ( |
) | ( |
) |
Net cash from operating activities | ( |
) |
Cash flows from investing activities |
Purchase of intangible fixed assets | ( |
) | ( |
) |
Purchase of tangible fixed assets | ( |
) | ( |
) |
Purchase of fixed asset investments | (21,000 | ) | - |
Interest received |
Net cash from investing activities | ( |
) | ( |
) |
Cash flows from financing activities |
New loans/(repayments) of loans | ( |
) |
Loans from/(to) directors | (59,167 | ) | (5,030 | ) |
Equity dividends paid | ( |
) | ( |
) |
Net cash from financing activities | ( |
) |
(Decrease)/increase in cash and cash equivalents | ( |
) |
Cash and cash equivalents at beginning of year |
2 |
170,532 |
Cash and cash equivalents at end of year | 2 | 413,593 | 754,807 |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
NOTES TO THE CASH FLOW STATEMENT |
for the year ended 31 December 2016 |
1. | RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS |
2016 | 2015 |
£ | £ |
Profit before taxation |
Depreciation charges |
Loss on disposal of fixed assets |
Finance costs | 293,500 | 356,945 |
Finance income | (986 | ) | (764 | ) |
2,451,203 | 4,623,240 |
Decrease/(increase) in stocks | ( |
) |
Decrease/(increase) in trade and other debtors | ( |
) |
Decrease in trade and other creditors | ( |
) | ( |
) |
Cash generated from operations | ( |
) |
2. | CASH AND CASH EQUIVALENTS |
The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect |
of these Balance Sheet amounts: |
Year ended 31 December 2016 |
31.12.16 | 1.1.16 |
£ | £ |
Cash and cash equivalents | 413,593 | 754,807 |
Year ended 31 December 2015 |
31.12.15 | 1.1.15 |
£ | £ |
Cash and cash equivalents | 754,807 | 170,532 |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
NOTES TO THE FINANCIAL STATEMENTS |
for the year ended 31 December 2016 |
1. | STATUTORY INFORMATION |
ID Medical Group Limited is a |
company's registered number and registered office address can be found on the Company Information |
page. |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
These financial statements have been prepared in accordance with Financial Reporting Standard 102 (FRS |
102) "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies |
Act 2006. Unless indicated otherwise in the accounting policies below, the financial statements have been |
prepared under the historical cost convention. |
The financial statements are prepared on a going concern basis as the directors consider this to be |
appropriate given the anticipated ongoing profitability of the business and on the basis that the company |
has sufficient financial resources which will allow the company to manage its business risks in the |
foreseeable future. |
The company has taken advantage of the following disclosure exemption in preparing these financial |
statements, as permitted by FRS 102 "The Financial Reporting Standard applicable in the UK and Republic |
of Ireland": |
• | the requirements of Section 11 Financial Instruments paragraphs 11.40 to 11.48(a). |
Preparation of consolidated financial statements |
The company accounts present information about it as an individual undertaking. The company is exempt |
under section 402 of the Companies Act 2006 from the requirements to prepare consolidated financial |
statements as the subsidiary undertakings are not material for the purpose of giving a true and fair view. |
Significant judgements and estimates |
The directors have made judgements and estimates in relation to accrued income, together with related |
accrued cost of sales, at the year end. Further detail is provided in the turnover and income recognition |
policy below. |
Turnover and income recognition |
Turnover represents the fair value of consideration receivable for the sale of services in the ordinary |
course of the business, excluding Value Added Tax. This includes the following: |
1. Turnover from temporary placements which represents amounts billed to customers for the services |
performed. This is recognised when the services are provided to the customer. |
2. Turnover from permanent placements which is recognised at the date when a candidate commences |
work. |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
for the year ended 31 December 2016 |
2. | ACCOUNTING POLICIES - continued |
Turnover and income recognition - continued |
For temporary placements, invoices are raised to customers after receipt of the timesheet from |
candidates. A provision for accrued income is recognised in the financial statements for outstanding |
timesheets not yet received from candidates and thus not yet billed to customers at the year end. This |
provision is calculated based on the company's best estimate of the value of timesheets to be received, |
which takes into account the anticipated sales value but is discounted to allow for the possibility that |
turnover may not be invoiced for timesheets not received. |
Intangible fixed assets |
Intangible fixed assets include the following: |
1. Website development costs which are capitalised where a return on investment can reasonably be |
regarded as assured. |
2. Computer software, where this is separately identifiable from assets of a tangible nature. |
Amortisation is provided at an annual rate of 33% on cost in order to write off the cost of each asset over |
its estimated useful life. |
Tangible fixed assets |
Depreciation is provided at the following annual rates in order to write off each asset over its estimated |
useful life. |
Short leasehold improvements - Over the period of the lease |
Office equipment - 33% or 20% on cost |
Computer equipment - 33% on cost |
Investments in subsidiaries |
Investments in subsidiary undertakings are recognised at cost. |
Stocks |
Stocks are valued at the lower of cost, using the first in first out method, and estimated selling price less |
costs to sell. |
Taxation |
Current tax is the amount of corporation tax payable in respect of the taxable profit for the year or prior |
years. Tax is calculated on the basis of tax rates and laws that have been enacted or substantively enacted |
by the period end. |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the |
balance sheet date where transactions or events that result in an obligation to pay more tax in the future |
or a right to pay less tax in the future have occurred at the balance sheet date. Timing differences are |
differences between the company's taxable profits and its results as stated in the financial statements. |
Deferred tax is measured at the average tax rates that are expected to apply in the periods in which |
timing differences are expected to reverse, based on tax rates and laws that have been enacted or |
substantially enacted by the balance sheet date. Deferred tax is measured on a non-discounted basis. |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
for the year ended 31 December 2016 |
2. | ACCOUNTING POLICIES - continued |
Foreign currencies |
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the |
balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange |
ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating |
result. |
Pension costs and other post-retirement benefits |
The company operates a defined contribution scheme. The amount charged to the statement of |
comprehensive income in respect of pension costs and other post retirement benefits is the contributions |
payable in the year. Differences between contributions payable in the year and contributions actually |
paid are shown as either accruals or prepayments in the balance sheet. |
The company uses invoice discounting to obtain finance in respect of trade debts issued to non-related |
companies. The company has full recourse for the debts. Invoice discounting costs are charged to the |
statement of comprehensive income for the period to which they relate. |
Operating leases |
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership |
remain with the lessor are charged to the statement of comprehensive income as incurred. The benefits |
of lease incentives are recognised in the statement of comprehensive income over the life of the lease. |
Fixed asset investments |
Fixed asset investments are stated at cost less provisions for diminution in value. |
Financial Instruments |
Basic financial instruments are recognised at amortised cost. |
3. | TURNOVER |
The turnover and profit before taxation are attributable to the one principal activity of the company. |
An analysis of turnover by geographical market is given below: |
2016 | 2015 |
£ | £ |
United Kingdom |
Europe |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
for the year ended 31 December 2016 |
4. | EMPLOYEES AND DIRECTORS |
2016 | 2015 |
£ | £ |
Wages and salaries |
Social security costs |
Other pension costs |
The average monthly number of employees during the year was as follows: |
2016 | 2015 |
Administration | 165 | 124 |
Marketing | 11 | 11 |
Sales | 318 | 358 |
The staff costs shown above are net of recharges made to Recruitment Express Limited and Group 24 |
Limited for salaries, social security and pension costs of £1,180,210 (2015: £1,627,417), £116,458 (2015: |
£164,067) and £5,892 (2015: £7,324) respectively. |
The pension costs relate to contributions payable into a defined contribution scheme. At the year end, |
contributions of £2,363 (2015: £501) were payable to the fund. |
5. | DIRECTORS' EMOLUMENTS |
2016 | 2015 |
£ |
Directors' remuneration | 1,579,746 | 2,093,166 |
Information regarding the highest paid director is as follows: |
Emoluments etc | 815,211 | 1,158,052 |
During the year, 3 (2015: 3) directors were accruing retirement benefits under a defined contribution |
scheme. The total directors' pension contributions during the year amounted to £1,110 (2015: £1,093), of |
which £370 (2015: £364) relates to the highest paid director. |
The highest paid director did not exercise any share options during the year. |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
for the year ended 31 December 2016 |
6. | OPERATING PROFIT |
The operating profit is stated after charging/(crediting): |
2016 | 2015 |
£ | £ |
Depreciation - owned assets | 344,781 | 356,108 |
Loss on disposal of fixed assets | 3,873 | - |
Amortisation of intangible assets | 320,323 | 288,425 |
Foreign exchange differences | 5,532 | (1,301 | ) |
Operating leases - land and buildings | 426,092 | 350,400 |
Operating leases - cars | 35,906 | 55,449 |
7. | AUDITORS' REMUNERATION |
2016 | 2015 |
£ | £ |
Audit fees | 16,453 | 15,076 |
Tax compliance fees | 4,977 | 5,132 |
Other non-audit fees | 18,986 | 15,491 |
40,416 | 35,699 |
8. | INTEREST PAYABLE AND SIMILAR EXPENSES |
2016 | 2015 |
£ | £ |
Bank loan interest |
Invoice discounting interest |
9. | TAXATION |
Analysis of the tax charge |
The tax charge on the profit for the year was as follows: |
2016 | 2015 |
£ | £ |
Current tax: |
UK corporation tax |
Prior year adjustment | ( |
) | ( |
) |
Total current tax |
Deferred tax | ( |
) |
Tax on profit |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
for the year ended 31 December 2016 |
9. | TAXATION - continued |
Reconciliation of total tax charge included in profit and loss |
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference |
is explained below: |
2016 | 2015 |
£ | £ |
Profit before tax |
Profit multiplied by the standard rate of corporation tax in the UK of |
Effects of: |
Expenses not deductible for tax purposes |
Adjustments to tax charge in respect of previous periods | ( |
) | ( |
) |
Rounding of tax provision |
Total tax charge | 302,115 | 748,637 |
10. | DIVIDENDS |
The aggregate dividends paid during the year totalled £1,400,000 (2015: £1,270,000). |
11. | INTANGIBLE FIXED ASSETS |
Website |
development | Computer |
costs | software | Totals |
£ | £ | £ |
COST |
At 1 January 2016 |
Additions |
At 31 December 2016 |
AMORTISATION |
At 1 January 2016 |
Amortisation for year |
At 31 December 2016 |
NET BOOK VALUE |
At 31 December 2016 |
At 31 December 2015 |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
for the year ended 31 December 2016 |
12. | TANGIBLE FIXED ASSETS |
Short |
leasehold | Office | Computer |
improvements | equipment | equipment | Totals |
£ | £ | £ | £ |
COST |
At 1 January 2016 |
Additions |
Disposals | ( |
) | ( |
) |
At 31 December 2016 |
DEPRECIATION |
At 1 January 2016 |
Charge for year | ( |
) |
Eliminated on disposal | ( |
) | ( |
) |
At 31 December 2016 |
NET BOOK VALUE |
At 31 December 2016 |
At 31 December 2015 |
13. | FIXED ASSET INVESTMENTS |
Interests in |
group |
undertakings |
£ |
COST |
At 1 January 2016 | 2 |
Additions | 21,000 |
At 31 December 2016 | 21,002 |
NET BOOK VALUE |
At 31 December 2016 | 21,002 |
At 31 December 2015 | 2 |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
for the year ended 31 December 2016 |
13. | FIXED ASSET INVESTMENTS - continued |
The company's fixed asset investments at the balance sheet date include the following: |
Aggregate capital and reserves |
Class of | % | 2016 | 2015 |
Company | shares | Holding | £ | £ |
ID Medical Limited | Ordinary | 100.00 | 1 | 1 |
ID Search & Selection Limited | Ordinary | 100.00 | 1 | 1 |
2 | 2 |
The above companies are dormant and registered at ID House, 1 Mill Square, Featherstone Road, |
Wolverton Mill, Milton Keynes, MK12 5ZD. |
Capital contribution |
% | 2016 | 2015 |
Limited Liability Partnership | Ownership | £ | £ |
ID Medical India LLP | 98.90 | 21,000 | - |
The above entity was set up shortly before the balance sheet date to provide administrative services to |
the company. The entity is registered at Unit 211, Second Floor, Tower 2 World Trade Center, Kharadi, |
Pune, MH 411014 IN. |
14. | STOCKS |
2016 | 2015 |
£ | £ |
Restaurant stock |
15. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
2016 | 2015 |
£ | £ |
Trade debtors |
Amounts owed by group undertakings |
Amounts owed by related companies |
Other debtors |
Directors' loan accounts |
Prepayments and accrued income |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
for the year ended 31 December 2016 |
16. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
2016 | 2015 |
£ | £ |
Bank loans (see note 18) |
Trade creditors |
Amounts owed to related companies |
Tax |
Social security and other taxes |
Other creditors |
Accruals and deferred income |
17. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
2016 | 2015 |
£ | £ |
Bank loans (see note 18) |
18. | LOANS |
An analysis of the maturity of loans is given below: |
2016 | 2015 |
£ | £ |
Amounts falling due within one year or on demand: |
Advance from invoice discounting company |
Bank loans | 112,484 | 109,421 |
Amounts falling due between two and five years: |
Bank loans |
The advance from the invoice discounting company of £15,041,806 (2015: £19,284,459) is secured by a |
fixed and floating charge over the assets of the company. |
Bank loans of £287,011 (2015: £396,409) relate to a loan from HSBC Bank Plc. Interest is charged at 2.25% |
above the Bank of England base rate and the loan is repayable over 4 years. At the year end, this loan is |
secured by fixed and floating charges over all assets and undertakings of the company. |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
for the year ended 31 December 2016 |
19. | LEASING AGREEMENTS |
Minimum lease payments under non-cancellable operating leases fall due as follows: |
2016 | 2015 |
£ | £ |
Within one year |
Between one and five years |
In more than five years |
The above minimum lease payments include amounts totalling £2,389,063 (2015: £2,814,887) which have |
been guaranteed by Recruitment Express Limited, a company under common control. |
20. | PROVISIONS FOR LIABILITIES |
2016 | 2015 |
£ | £ |
Deferred tax | 54,000 | 82,000 |
Deferred |
tax |
£ |
Balance at 1 January 2016 |
Decelerated capital allowances | ( |
) |
Change in future tax rate | (3,000 | ) |
Balance at 31 December 2016 |
21. | CALLED UP SHARE CAPITAL |
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 2016 | 2015 |
value: | £ | £ |
Ordinary | 2p | 100 | 100 |
The company has one class of ordinary shares which carry full rights with regards to voting participation |
and dividends. |
During 2013, options were issued to two of the directors, under the Enterprise Management Incentive |
scheme, to acquire up to a combined total of 567 B Ordinary shares. |
The options may be exercised, at an exercise price of £382 per share, in the event of a sale of the business |
and in certain other instances as set out in the scheme rules, subject to certain conditions, within a period |
of 10 years from the date on which the options were granted. |
No options were exercised during the year under review. |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
for the year ended 31 December 2016 |
22. | RESERVES |
Retained |
earnings |
£ |
At 1 January 2016 |
Profit for the year |
Dividends | ( |
) |
At 31 December 2016 |
The company's retained earnings above represents cumulative profits or losses net of dividends paid and |
other adjustments. |
23. | CONTINGENT LIABILITIES |
At 31 December 2016 the company held bank facilities in a group with Recruitment Express Limited and |
Group 24 Limited, companies under common control, in respect of loans from HSBC Invoice Finance (UK) |
Limited. These were supported by cross guarantees, the total liability of which was £16,155,390 (2015: |
£20,687,512) at the year end. Of this amount £15,041,806 (2015: £19,284,459) is included as a creditor |
in these financial statements, £809,047 (2015: £1,131,241) is included as a creditor in the financial |
statements of Recruitment Express Limited and £304,537 (2015: £271,812) is included as a creditor in the |
financial statements of Group 24 Limited. |
The company does not anticipate that this guarantee will be called upon. |
24. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES |
The following loans to directors subsisted during the year ended 31 December 2016: |
2016 | 2015 |
£ | £ |
Balance outstanding at start of year | 58,741 | 53,711 |
Amounts advanced | 575,302 | 63,332 |
Amounts repaid | (516,135 | ) | (58,302 | ) |
Balance outstanding at end of year | 117,908 | 58,741 |
The above loans are interest free and repayable on demand. |
ID MEDICAL GROUP LIMITED (REGISTERED NUMBER: 03829536) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
for the year ended 31 December 2016 |
25. | RELATED PARTY DISCLOSURES |
At 31 December 2016 the company was owed £214,625 by (2015: £2,493 owed to) Media Marketing |
Research International Limited, a company controlled by Dr M H A Sacoor. During the year Media |
Marketing Research International Limited recharged the company administrative expenses of £133,307 |
(2015: £108,566). A further £Nil (2015: £48,600) was charged by Media Marketing Research International |
Limited for consultancy services. |
At 31 December 2016 the company owed £816,378 (2015: £161,161) to Recruitment Express Limited, a |
company controlled equally by Dr M H A Sacoor and M Sacoor. During the year the company recharged |
administrative expenses of £1,508,448 (2015: £1,434,052) and cost of sales of £102,222 were recharged |
by (2015 recharged to: £29,059) Recruitment Express Limited. |
At 31 December 2016 the company owed £246,692 to (2015: £34,722 owed by) Group 24 Limited. During |
the year, the company recharged administrative expenses to Group 24 Limited of £139,196 (2015: |
£853,124) and Group 24 Limited recharged costs of sales of £1,607,501 (2015: £1,584,808) to the |
company. Group 24 Limited is a company controlled equally by Dr M H A Sacoor and M Sacoor. |
All of the related company balances referred to above are interest free and repayable on demand. |
During the year, the company paid total dividends of £1,400,000 (2015: £1,270,000) to the shareholders |
who are also directors. |
26. | POST BALANCE SHEET EVENTS |
After the year end, the company took out an additional loan facility from HSBC Bank Plc of £3,000,000 |
repayable over two years. This facility is secured by fixed and floating charges over all the assets of the |
company and by guarantees from Recruitment Express Limited and Group 24 Limited, companies under |
common control. Two of the directors have also provided a personal guarantee limited to £1,000,000. |
The company does not anticipate that these guarantees will be called upon. |
27. | ULTIMATE CONTROLLING PARTY |